Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Sets New 52-Week High – Here’s What Happened

Invesco Pharmaceuticals ETF (NYSEARCA:PJP)’s stock price hit a new 52-week high during mid-day trading on Thursday. The company traded as high as $132.41 and last traded at $132.3850, with a volume of 2,566 shares. The stock had previously closed at $131.59.

Invesco Pharmaceuticals ETF Trading Down 2.1%

The stock’s 50-day moving average is $125.78 and its 200-day moving average is $114.83. The stock has a market cap of $586.02 million, a price-to-earnings ratio of 28.57 and a beta of 0.43.

Institutional Investors Weigh In On Invesco Pharmaceuticals ETF

Several large investors have recently made changes to their positions in the business. Joseph Group Capital Management lifted its holdings in shares of Invesco Pharmaceuticals ETF by 2.4% during the 3rd quarter. Joseph Group Capital Management now owns 23,514 shares of the company’s stock valued at $2,900,000 after acquiring an additional 548 shares in the last quarter. Means Investment CO. Inc. acquired a new stake in Invesco Pharmaceuticals ETF in the 3rd quarter valued at $363,000. Commonwealth Equity Services LLC acquired a new stake in Invesco Pharmaceuticals ETF in the 3rd quarter valued at $994,000. Schmidt P J Investment Management Inc. acquired a new stake in Invesco Pharmaceuticals ETF in the 3rd quarter valued at $449,000. Finally, Chicago Partners Investment Group LLC purchased a new position in Invesco Pharmaceuticals ETF in the third quarter valued at about $236,000.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.